ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

Univ. Of Washington, Fox Chase, ICC Win CCRU, CCSP Awards

July 8, 1983

DCCR Advisory Committee Delays Planned Expansion Of Promising Community Clinical Oncology Program

July 21, 1978

Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.

June 27, 2003

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

Mammography Panel Reaches Consensus On Most Issues

September 23, 1977

St. Jude Offers Three Fellowships

May 3, 1985